MedTrace Logo

Protocol For Collecting Data On Patients With Childhood Cancer

NCT00684580 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2026-04-29

No results posted yet for this study

Summary

Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.

Conditions

  • Childhood Cancer

Interventions

OTHER

Data Collection

Continuing review of outcomes and late toxicities

Sponsors & Collaborators

Principal Investigators

  • Melissa M Hudson, MD · St. Jude Children's Research Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-06-08
Primary Completion
2045-05-31
Completion
2045-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00684580 on ClinicalTrials.gov